They most like had all of the first dose results at the time the patent was filed considering when the results were released. Also the math wouldn't make sense for these results to be from the low dose cohort.
From what I understand the Immune response isn't sustained indefinitely. which opens up the door for vaccinated people becoming infected.
I think more to the point the affiliation with the scientific minds at Advaxis has benefited Carl June and U-Penn as we are light years ahead in studies! I didn't think you would get the inference, so there it is, I spelled it out for you!
Or at least until the agreement runs it's course and Socius gets their shares. The company will probably give a PR at that point to run the share price up with the help of Socius and Optimus so they can sell their shares at a lot higher price! Like I said, it wouldn't surprise me if they are all scratching each others back in this deal. Theirs no way Numoda would sell our debt without discussing it with Advaxis first, no way!
Truth be told they are probably all in on it, Tom Moore included! I can't believe that the agreement advaxis made with Socius RE average share price(and the beating down of our share price since) isn't raising some red flags with the SEC! The company seems all too cozy with this arrangement and the with what the share price is doing.
I would rather not have a licensing deal then to give away our technology for nothing. I would rather try and get early approval to market one of the constructs and force big pharmas hand with regard to the company.
Who knows maybe our goals as a company who wants to license after phase 2 will change if we can get early approval to market the construct for 1 or more of the indications for which it is being tested. Tom Moore doesn't seem phased by the share price and he has plenty of shares, so I guess I'm willing to wait and let this run its course.
If you can't read and interpret what you read in an intelligent fashion than please stop posting on our message board. Novartis is interested in all therapies coming out of U-Penn and are essentially gaining a monopoly on them.
That's a big vote of confidence since our therapy was developed at U-Penn and we won the vaccine of the year award at Novartis's conference.
Oh, did I mention that Carl June is on our scientific advisory board?
Just because our market cap is 22 mill doesn't mean that that is what we're worth. We're worth more than the last day manipulation reflects, a whole lot more! Tom wont hand over this peach for pennies on the dollar, I think he know what we've got!
Let's hope they are not trying to get their hands on our tech by stoking U-Penn! It wouldn't surprise me if that was the case. Let's hope Tom Moore has everything locked up tight! After all, it was their conference that we were judged immunotherapy of the year at.
I agree onebite! It's just a matter of time before the manipulators let it be known what's going on here! After they've gobbled up all of the loose shares from the market, they'll take off the strangle hold and start pumping this thing as hard as they've strangled it! There's going to be a lot of losers who are hot under the collar when it happens and they sold their share on the slide down.
If you have the goods and by all accounts it appears we do than this will send the SP hurtling skywards.
I must have hit a sore spot. I think it's exactly like a described it. I see your bashing colors are coming to the surface just like the days of old when you first came to this board!
The company has put themselves in this situation with the number of shares on the market and lack of PRs. When management realizes that there is a big correlation between share price and their ability to raise money with minimal dilution we will have something here. As for now they have painted a big red X on back when it comes to venture capitalist. In my opinion we need ground shaking news followed by a reverse split to reduce the number of shares available for manipulation. These guys wont attempt the scenario above that I have described if the share count is low enough because our shares will be coveted. Any put on the market will be immediately grabbed up.
I know a lot of people will say we don't need this but I think if it was done our SP would immediately explode as our SP would explode. The science and results are there, we just need vocalization of great CIN results results followed by a reduction in the share count. Mark my words, if the following is done all of those people complaining about a reverse split would be very happy campers when this rocket sled takes off.